These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


76 related items for PubMed ID: 1996080

  • 41. Angiotensin II vs its type I antagonists: conformational requirements for receptor binding assessed from NMR spectroscopic and receptor docking experiments.
    Wilkes BC, Masaro L, Schiller PW, Carpenter KA.
    J Med Chem; 2002 Sep 26; 45(20):4410-8. PubMed ID: 12238921
    [Abstract] [Full Text] [Related]

  • 42. Synthesis and biological activity of angiotensin II analogues containing a Val-His replacement, Val psi[CH(CONH2)NH]His.
    Mohan R, Chou YL, Bihovsky R, Lumma WC, Erhardt PW, Shaw KJ.
    J Med Chem; 1991 Aug 26; 34(8):2402-10. PubMed ID: 1875337
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors.
    Schambye HT, Hjorth SA, Bergsma DJ, Sathe G, Schwartz TW.
    Proc Natl Acad Sci U S A; 1994 Jul 19; 91(15):7046-50. PubMed ID: 8041743
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Mutation of Asn111 in the third transmembrane domain of the AT1A angiotensin II receptor induces its constitutive activation.
    Groblewski T, Maigret B, Larguier R, Lombard C, Bonnafous JC, Marie J.
    J Biol Chem; 1997 Jan 17; 272(3):1822-6. PubMed ID: 8999867
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Cloning and characterization of a human angiotensin II type 1 receptor.
    Bergsma DJ, Ellis C, Kumar C, Nuthulaganti P, Kersten H, Elshourbagy N, Griffin E, Stadel JM, Aiyar N.
    Biochem Biophys Res Commun; 1992 Mar 31; 183(3):989-95. PubMed ID: 1567413
    [Abstract] [Full Text] [Related]

  • 49. Spiral calcium wave propagation and annihilation in Xenopus laevis oocytes.
    Lechleiter J, Girard S, Peralta E, Clapham D.
    Science; 1991 Apr 05; 252(5002):123-6. PubMed ID: 2011747
    [Abstract] [Full Text] [Related]

  • 50. Chloride current assay for phospholipase C in Xenopus oocytes.
    Landau EM, Blitzer RD.
    Methods Enzymol; 1994 Apr 05; 238():140-54. PubMed ID: 7799781
    [No Abstract] [Full Text] [Related]

  • 51. Novel non-peptide angiotensin II receptor antagonists.
    Timmermans PB, Chiu AT, Smith RD, Wong PC.
    Proc West Pharmacol Soc; 1992 Apr 05; 35():65-71. PubMed ID: 1502242
    [No Abstract] [Full Text] [Related]

  • 52. Mutations in transmembrane segment VII of the AT1 receptor differentiate between closely related insurmountable and competitive angiotensin antagonists.
    Schambye HT, von Wijk B, Hjorth SA, Wienen W, Entzeroth M, Bergsma DJ, Schwartz TW.
    Br J Pharmacol; 1994 Oct 05; 113(2):331-3. PubMed ID: 7834178
    [Abstract] [Full Text] [Related]

  • 53. Ligand-binding assays in Xenopus oocytes.
    Buller AL, White MM.
    Methods Enzymol; 1992 Oct 05; 207():368-75. PubMed ID: 1382192
    [No Abstract] [Full Text] [Related]

  • 54. Proposals for the angiotensin II receptor-bound conformation by comparative computer modeling of AII and cyclic analogs.
    Joseph MP, Maigret B, Scheraga HA.
    Int J Pept Protein Res; 1995 Dec 05; 46(6):514-26. PubMed ID: 8748712
    [Abstract] [Full Text] [Related]

  • 55. The difficult challenge of cloning the angiotensin II receptor.
    Weber V, Monnot C, Bihoreau C, Corvol P, Clauser E.
    Horm Res; 1990 Dec 05; 34(3-4):101-4. PubMed ID: 2104393
    [Abstract] [Full Text] [Related]

  • 56. Comparative analysis of amphibian and mammalian angiotensin receptors.
    Sandberg K, Ji H.
    Comp Biochem Physiol A Mol Integr Physiol; 2001 Jan 05; 128(1):53-75. PubMed ID: 11137439
    [Abstract] [Full Text] [Related]

  • 57. Robotic automation of Xenopus oocyte bath perfusion.
    Mihic SJ, Harris RA.
    Biotechniques; 1996 May 05; 20(5):802-4. PubMed ID: 8723922
    [No Abstract] [Full Text] [Related]

  • 58. Effects of angiotensin II antagonists on the contractile and hydrosmotic effect of AT II and AT III in the toad (Bufo arenarum).
    Peral de Bruno M, Coviello A.
    J Comp Physiol B; 1996 May 05; 165(7):565-70. PubMed ID: 8617893
    [Abstract] [Full Text] [Related]

  • 59. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors.
    Schambye HT, Hjorth SA, Bergsma DJ, Sathe G, Schwartz TW.
    Proc Natl Acad Sci U S A; 1994 Jul 19; 91(15):7046-50. PubMed ID: 8041743
    [Abstract] [Full Text] [Related]

  • 60. Genetic transfer of a nonpeptide antagonist binding site to a previously unresponsive angiotensin receptor.
    Ji H, Zheng W, Zhang Y, Catt KJ, Sandberg K.
    Proc Natl Acad Sci U S A; 1995 Sep 26; 92(20):9240-4. PubMed ID: 7568109
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.